- News & Features
What did you wish you knew...? Join us on Monday July 10th to share tips and practices that make living with a chronic disease a little bit easier.
A Kaiser Family Foundation analysis finds significant increases in 2020 health insurance premiums under the controversial Senate healthcare bill among those who receive tax credits.
Millions of Americans are adopting gluten-free diets, but is this really necessary? A New York Times article takes a closer look.
You’ve no doubt heard the controversy over the recently unveiled Senate healthcare bill, but exactly what’s in it and how will it affect you if it becomes law?
Postmenopausal women with osteoporosis who took romosozumab for a year experienced “rapid and large reductions" in risk of fracturing vertebrae.
EULAR report highlights the importance of early intervention in the treatment of people with rheumatic and musculoskeletal diseases.
It’s a tale of two guidelines for consuming alcohol while taking methotrexate (MTX). “Alcohol significantly increases the risk for liver...
The results of the Norwegian study “show that efficacy and safety were comparable between patients switched to CT-P13 and those who continued treatment with reference infliximab, proving that patients can be safely switched to CT-P13.
The U.S. Food and Drug Administration recently approved sarilumab, an interleukin-6 (IL-6) receptor blocker, for treatment of adult rheumatoid arthritis patients.
Researchers have found a connection between delayed axial spondyloarthritis diagnosis and depression.
The drug tanezumab, is an injectable biologic and may be available as soon as 2018.